Literature DB >> 31446520

Role of JNK Signaling Pathway in Dexmedetomidine Post-Conditioning-Induced Reduction of the Inflammatory Response and Autophagy Effect of Focal Cerebral Ischemia Reperfusion Injury in Rats.

Yulin Zhu1, Shihong Li2, Jingying Liu3, Qing Wen4, Jingui Yu5, Lingzhi Yu6, Kun Xie7.   

Abstract

To investigate the effect of dexmedetomidine post-conditioning on the inflammatory response and autophagy effect of focal cerebral ischemia reperfusion injury in rats, and further to study its potential mechanisms. Water maze was conducted to evaluate spatial learning and memory ability of middle cerebral artery occlusion (MCAO) rats. TTC staining was used to observe the area of cerebral infarction. The expressions of inflammatory factors in serum were detected by ELISA. TUNEL assay, HE staining, and transmission electron microscopy were used to detect the apoptosis of neurons, neuro-cytopathic changes, and the formation of auto-phagosome in hippocampus CA1 region, respectively. The mRNA and protein expression of Beclin-1, Caspase-3, and light chain 3 (LC3) were detected by qRT-PCR and Western blot. Moreover, the activity of C-Jun N-terminal kinase (JNK) pathway was detected by Western blot. The escape latency (EL); cerebral infarction area ratio; positive apoptosis; neuron pathological changes; auto-phagosome numbers; inflammatory factor contents; mRNA and protein expressions of Beclin-1, Caspase-3 and LC3II/I; and the phosphorylation level of JNK were decreased, while the times across platform and the times stayed in the quadrant of the original platform were increased after dexmedetomidine treatment. However, the protective effect of dexmedetomidine on brain injury in MCAO rats was reversed by JNK pathway activator. Dexmedetomidine post-conditioning could improve learning and memory dysfunction caused by MCAO in rats and reduce the inflammatory response and autophagy effect. The mechanism may be related to inhibition of JNK pathway activation.

Entities:  

Keywords:  Autophagy; Dexmedetomidine; Inflammation; Ischemia reperfusion injury; JNK signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 31446520     DOI: 10.1007/s10753-019-01082-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  1 in total

1.  Effect of polydatin on expression of p53 and Notch1 in brain tissue of ischemic cerebrovascular disease.

Authors:  F Y Chen; X Y Fang; H Zhang
Journal:  J Biol Regul Homeost Agents       Date:  2018 Jan-Feb       Impact factor: 1.711

  1 in total
  12 in total

Review 1.  Novel Therapeutic Strategies for Ischemic Stroke: Recent Insights into Autophagy.

Authors:  Xiaocheng Lu; Jian Zhang; Yu Ding; Jiang Wu; Gang Chen
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

2.  Dexmedetomidine alleviates inflammatory response and oxidative stress injury of vascular smooth muscle cell via α2AR/GSK-3β/MKP-1/NRF2 axis in intracranial aneurysm.

Authors:  Ze Zhang; Xiue Mu; Xiaohui Zhou
Journal:  BMC Pharmacol Toxicol       Date:  2022-10-23       Impact factor: 2.605

3.  Hypothyroidism Induces Interleukin-1-Dependent Autophagy Mechanism as a Key Mediator of Hippocampal Neuronal Apoptosis and Cognitive Decline in Postnatal Rats.

Authors:  Juhi Mishra; Jitendra Vishwakarma; Rafat Malik; Keerti Gupta; Rukmani Pandey; Shailendra Kumar Maurya; Asmita Garg; Manoj Shukla; Naibedya Chattopadhyay; Sanghamitra Bandyopadhyay
Journal:  Mol Neurobiol       Date:  2020-10-26       Impact factor: 5.590

Review 4.  Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics.

Authors:  Amir Ajoolabady; Shuyi Wang; Guido Kroemer; Josef M Penninger; Vladimir N Uversky; Domenico Pratico; Nils Henninger; Russel J Reiter; Askiel Bruno; Kaumudi Joshipura; Hamid Aslkhodapasandhokmabad; Daniel J Klionsky; Jun Ren
Journal:  Pharmacol Ther       Date:  2021-04-03       Impact factor: 13.400

5.  Propofol Attenuates Hypoxia/Reoxygenation-Induced Apoptosis and Autophagy in HK-2 Cells by Inhibiting JNK Activation.

Authors:  Huaxin Wang; Xuan Peng; Yayi Huang; Yeda Xiao; Zhuo Wang; Liying Zhan
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

6.  Dexmedetomidine and Netrin-1 Combination Therapy Inhibits Endoplasmic Reticulum Stress by Regulating the ERK5/MEF2A Pathway to Attenuate Cerebral Ischemia Injury.

Authors:  Jiang-Wen Yin; Jia Li; Yi-Min Ren; Yan Li; Rui-Xue Wang; Sheng Wang; Yun-Xia Zuo
Journal:  Front Neurosci       Date:  2021-01-28       Impact factor: 4.677

7.  Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis.

Authors:  Wenyi Liu; Cuihua Shao; Chuanshan Zang; Jian Sun; Min Xu; Yuna Wang
Journal:  BMC Anesthesiol       Date:  2021-08-16       Impact factor: 2.217

Review 8.  Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy.

Authors:  Shankun Zhao; Weizhou Wu; Xuezheng Lin; Maolei Shen; Zhenyu Yang; Sicong Yu; Yu Luo
Journal:  Cell Mol Biol Lett       Date:  2022-05-04       Impact factor: 8.702

9.  Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.

Authors:  Hengchang Li; Chengxiang Lu; Wenfei Yao; Lixin Xu; Jun Zhou; Bin Zheng
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

10.  Shenzhi Jiannao formula ameliorates vascular dementia in vivo and in vitro by inhibition glutamate neurotoxicity via promoting clathrin-mediated endocytosis.

Authors:  Danfeng Tian; Yangyang Guo; Dandan Zhang; Qiang Gao; Ganlu Liu; Jingfeng Lin; Ze Chang; Yuchun Wang; Rui Su; Zhenyun Han
Journal:  Chin Med       Date:  2021-07-28       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.